Intratreatment Response Assessment With 18F-FDG PET: Correlation of Semiquantitative PET Features With Pathologic Response of Esophageal Cancer to Neoadjuvant Chemoradiotherapy
- 1 November 2018
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 102 (4) , 1002-1007
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinomaBritish Journal of Cancer, 2011
- Fluorodeoxyglucose Positron Emission Tomography for Evaluating Early Response During Neoadjuvant Chemoradiotherapy in Patients With Potentially Curable Esophageal CancerAnnals of Surgery, 2011
- Early Repeated 18F-FDG PET Scans During Neoadjuvant Chemoradiation Fail to Predict Histopathologic Response or Survival Benefit in Adenocarcinoma of the EsophagusJournal of Nuclear Medicine, 2010
- Prognostic Value of Metabolic Tumor Volume Measured by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Esophageal CarcinomaAnnals of Surgical Oncology, 2009
- Complete Pathologic Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Is Associated With Enhanced SurvivalThe Annals of Thoracic Surgery, 2009
- Metabolic Imaging Predicts Response, Survival, and Recurrence in Adenocarcinomas of the Esophagogastric JunctionJournal of Clinical Oncology, 2006
- 18FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour responseBritish Journal of Cancer, 2006
- Pathological response following long‐course neoadjuvant chemoradiotherapy for locally advanced rectal cancerHistopathology, 2005
- Evaluation of Response to Neoadjuvant Therapy by Quantitative 2-Deoxy-2-[18F]Fluoro-D-Glucose with Positron Emission Tomography in Patients with Esophageal CancerMolecular Imaging and Biology, 2002
- Writing for EpidemiologyEpidemiology, 1998